AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-87
Results: 26-50/87
PHASE-II STUDY OF GEMCITABINE IN PRETREATED HODGKINS-DISEASE RESULTS OF A MULTICENTER STUDY
Authors: TESCH H SANTORO A FIEDLER F BONADONNA G BREDENFELD K OLIVA C BUKSMAUI S SIEBER M DIEHL V
Citation: H. Tesch et al., PHASE-II STUDY OF GEMCITABINE IN PRETREATED HODGKINS-DISEASE RESULTS OF A MULTICENTER STUDY, Blood, 90(10), 1997, pp. 1514-1514
RANDOMIZED PHASE-II EVALUATION OF FLUDARABINE (RDA) AND 2-CHLOREDEOSSIADENOSINE (CDA) IN THE TREATMENT OF RELAPSED REFRACTORY LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) AND CLL/
Authors: TONDINI C BALZAROTTI M RAMPINELLI I LUONI M DEPAOLI A VALAGUSSA P SANTORO A BAJETTA E BONADONNA G BREGNI M
Citation: C. Tondini et al., RANDOMIZED PHASE-II EVALUATION OF FLUDARABINE (RDA) AND 2-CHLOREDEOSSIADENOSINE (CDA) IN THE TREATMENT OF RELAPSED REFRACTORY LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) AND CLL/, Blood, 90(10), 1997, pp. 1532-1532
VINORELBINE - A NEW PROMISING DRUG IN HODGKINS-DISEASE
Authors: DEVIZZI L SANTORO A BONFANTE V VIVIANI S BONADONNA G
Citation: L. Devizzi et al., VINORELBINE - A NEW PROMISING DRUG IN HODGKINS-DISEASE, Leukemia & lymphoma, 22(5-6), 1996, pp. 409-414
CURRENT AND FUTURE-TRENDS IN THE MULTIDISCIPLINARY APPROACH FOR HIGH-RISK BREAST-CANCER - THE EXPERIENCE OF THE MILAN-CANCER-INSTITUTE
Authors: BONADONNA G
Citation: G. Bonadonna, CURRENT AND FUTURE-TRENDS IN THE MULTIDISCIPLINARY APPROACH FOR HIGH-RISK BREAST-CANCER - THE EXPERIENCE OF THE MILAN-CANCER-INSTITUTE, European journal of cancer, 32A(2), 1996, pp. 209-214
ACTIVITY OF SINGLE-AGENT VINORELBINE IN PRETREATED NON-HODGKINS-LYMPHOMA
Authors: BALZAROTTI M SANTORO A TONDINI C FORNIER M BONADONNA G
Citation: M. Balzarotti et al., ACTIVITY OF SINGLE-AGENT VINORELBINE IN PRETREATED NON-HODGKINS-LYMPHOMA, Annals of oncology, 7(9), 1996, pp. 970-972
ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE AND FLUOROURACIL IN NODE-NEGATIVE AND ESTROGEN RECEPTOR-NEGATIVE BREAST-CANCER - UPDATED RESULTS
Authors: ZAMBETTI M VALAGUSSA P BONADONNA G
Citation: M. Zambetti et al., ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE AND FLUOROURACIL IN NODE-NEGATIVE AND ESTROGEN RECEPTOR-NEGATIVE BREAST-CANCER - UPDATED RESULTS, Annals of oncology, 7(5), 1996, pp. 481-485
EFFECTS OF ADJUVANT SYSTEMIC TREATMENTS IN BREAST-CANCER
Authors: VALAGUSSA P BONADONNA G
Citation: P. Valagussa et G. Bonadonna, EFFECTS OF ADJUVANT SYSTEMIC TREATMENTS IN BREAST-CANCER, Annals of oncology, 7(3), 1996, pp. 221-222
ALTERNATING VERSUS HYBRID MOPP AND ABVD COMBINATIONS IN ADVANCED HODGKINS-DISEASE - 10-YEAR RESULTS
Authors: VIVIANI S BONADONNA G SANTORO A BONFANTE V ZANINI M DEVIZZI L SONCINI F VALAGUSSA P
Citation: S. Viviani et al., ALTERNATING VERSUS HYBRID MOPP AND ABVD COMBINATIONS IN ADVANCED HODGKINS-DISEASE - 10-YEAR RESULTS, Journal of clinical oncology, 14(5), 1996, pp. 1421-1430
COMPARATIVE EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER HIGH-DOSE CYCLOPHOSPHAMIDE CANCER-THERAPY
Authors: BREGNI M SIENA S DINICOLA M DODERO A PECCATORI F RAVAGNANI F DANESINI G LAFFRANCHI A BONADONNA G GIANNI AM
Citation: M. Bregni et al., COMPARATIVE EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER HIGH-DOSE CYCLOPHOSPHAMIDE CANCER-THERAPY, Journal of clinical oncology, 14(2), 1996, pp. 628-635
INTERMEDIATE DOSES OF CYCLOPHOSPHAMIDE ALONE OR FOLLOWING ADRIAMYCIN IN ADVANCED BREAST-CANCER - A PILOT-STUDY
Authors: ZAMBETTI M TERENZIANI M BARTOLI C VALAGUSSA P PIOTTI P FERRANTI C BONADONNA G
Citation: M. Zambetti et al., INTERMEDIATE DOSES OF CYCLOPHOSPHAMIDE ALONE OR FOLLOWING ADRIAMYCIN IN ADVANCED BREAST-CANCER - A PILOT-STUDY, American journal of clinical oncology, 19(1), 1996, pp. 82-86
TIME DISTRIBUTION OF THE RECURRENCE RISK FOR BREAST-CANCER PATIENTS UNDERGOING MASTECTOMY - FURTHER SUPPORT ABOUT THE CONCEPT OF TUMOR DORMANCY
Authors: DEMICHELI R ABBATTISTA A MICELI R VALAGUSSA P BONADONNA G
Citation: R. Demicheli et al., TIME DISTRIBUTION OF THE RECURRENCE RISK FOR BREAST-CANCER PATIENTS UNDERGOING MASTECTOMY - FURTHER SUPPORT ABOUT THE CONCEPT OF TUMOR DORMANCY, Breast cancer research and treatment, 41(2), 1996, pp. 177-185
VINORELBINE - AN ACTIVE, NON CROSS-RESISTANT DRUG IN ADVANCED BREAST-CANCER - RESULTS FROM A PHASE-II STUDY
Authors: TERENZIANI M DEMICHELI R BRAMBILLA C FERRARI L MOLITERNI A ZAMBETTI M CARACENI A MARTINI C BONADONNA G
Citation: M. Terenziani et al., VINORELBINE - AN ACTIVE, NON CROSS-RESISTANT DRUG IN ADVANCED BREAST-CANCER - RESULTS FROM A PHASE-II STUDY, Breast cancer research and treatment, 39(3), 1996, pp. 285-291
OVARIAN ABLATION IN EARLY BREAST-CANCER - OVERVIEW OF THE RANDOMIZED TRIALS
Authors: CLARKE M COLLINS R DAVIES C GODWIN J GRAY R PETO R ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M VANDEVELDE AO VANDONGEN JA VERMORKEN JB ARVELAKIS A GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP PEEK U OATES GD POWELL J BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL CIRRINCIONE C KORZUN A WEISS RB WOOD WC BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A HORGAN K HUGHES L STEWART HJ GORDON NH DAVIS HL LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ ABELOFF MD CARBONE PC GLICK J TORMEY DC ROSSBACH J SCANLON EF SCHURMAN S DESCHRYVER A YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLEFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVALLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S TASUTOMI T SONOO H YAMASHITA J OGAWA M HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S AHMANN D SCHAID DJ BUZDAR AU SMITH T HAKES T NORTON L WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM BROWN A FISHER B REDMOND C WOLMARK N JACKSON IM PALMER MK INGLE JN SUMAN VJ BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR NAKAMURA Y MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MYLES JD PATER JL PRITCHARD KI MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST A CROSSLEY E DURRANT K HARRIS A BEIGHTON A COLLINS R EVANS V GREAVES E HARWOOD C JAMES S LAU E MEAD G MULDAL A NAUGHTON A TOOTH A WHEATLEY K RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPEILMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CJ ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P HOST H BRYANT AJS EWING GH KRUSHENKOSLOSKI JL FORREST APM JACK W MCDONALD C MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC JAKESZ R GNANT M BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: M. Clarke et al., OVARIAN ABLATION IN EARLY BREAST-CANCER - OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 348(9036), 1996, pp. 1189-1196
INTRODUCTION - BREAST-CANCER
Authors: BONADONNA G
Citation: G. Bonadonna, INTRODUCTION - BREAST-CANCER, Seminars in oncology, 23(4), 1996, pp. 413-413
PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER
Authors: BONADONNA G VALAGUSSA P
Citation: G. Bonadonna et P. Valagussa, PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER, Seminars in oncology, 23(4), 1996, pp. 464-474
FUTURE-DEVELOPMENTS FOR PACLITAXEL IN THE TREATMENT OF BREAST-CANCER
Authors: BONADONNA G
Citation: G. Bonadonna, FUTURE-DEVELOPMENTS FOR PACLITAXEL IN THE TREATMENT OF BREAST-CANCER, Seminars in oncology, 23(1), 1996, pp. 65-68
PACLITAXEL IN METASTATIC BREAST-CANCER - A TRIAL OF 2 DOSES BY A 3-HOUR INFUSION IN PATIENTS WITH DISEASE RECURRENCE AFTER PRIOR THERAPY WITH ANTHRACYCLINES
Authors: GIANNI L MUNZONE E CAPRI G VILLANI F SPREAFICO C TARENZI E FULFARO F CARACENI A MARTINI C LAFFRANCHI A VALAGUSSA P BONADONNA G
Citation: L. Gianni et al., PACLITAXEL IN METASTATIC BREAST-CANCER - A TRIAL OF 2 DOSES BY A 3-HOUR INFUSION IN PATIENTS WITH DISEASE RECURRENCE AFTER PRIOR THERAPY WITH ANTHRACYCLINES, Journal of the National Cancer Institute, 87(15), 1995, pp. 1169-1175
FROM ADJUVANT TO NEOADJUVANT CHEMOTHERAPY FOR HIGH-RISK BREAST
Authors: BONADONNA G
Citation: G. Bonadonna, FROM ADJUVANT TO NEOADJUVANT CHEMOTHERAPY FOR HIGH-RISK BREAST, European journal of cancer, 31A, 1995, pp. 43-43
A NEW STAGING SYSTEM FOR SMALL-CELL LUNG-CANCER (SCLC) - A PROPOSAL
Authors: SANTORO A PARRA HS BIDOLI P SALVINI PM ANGELIDOU M CATALDO I VALAGUSSA P BONADONNA G
Citation: A. Santoro et al., A NEW STAGING SYSTEM FOR SMALL-CELL LUNG-CANCER (SCLC) - A PROPOSAL, European journal of cancer, 31A, 1995, pp. 93-93
PACLITAXEL BY 3-H ON DAY 1 AND 8 EVERY 3-WEEKS IN WOMEN WITH ANTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER
Authors: GIANNI L FULFARO F TARENZI E MUNZONE E CAPRI G LAFFRANCHI A SPREAFICO C CRABEELS D BONADONNA G
Citation: L. Gianni et al., PACLITAXEL BY 3-H ON DAY 1 AND 8 EVERY 3-WEEKS IN WOMEN WITH ANTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 359-359
CHEMOTHERAPY (CT) WITH RADIOTHERAPY (RT) - LARYNX PRESERVATION STRATEGY IN CERVICAL SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS (CSCCE)
Authors: BIDOLI P PARRA HS SANTORO A VALENTE M CANTU G ZUCALI R RAVASI G BONADONNA G
Citation: P. Bidoli et al., CHEMOTHERAPY (CT) WITH RADIOTHERAPY (RT) - LARYNX PRESERVATION STRATEGY IN CERVICAL SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS (CSCCE), European journal of cancer, 31A, 1995, pp. 398-398
CHEMOTHERAPY (CT) WITH RADIOTHERAPY (RT) - LARYNX PRESERVATION STRATEGY IN CERVICAL SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS (CSCCE)
Authors: BIDOLI P PARRA HS SANTORO A VALENTE M CANTU G ZUCALI R RAVASI G BONADONNA G
Citation: P. Bidoli et al., CHEMOTHERAPY (CT) WITH RADIOTHERAPY (RT) - LARYNX PRESERVATION STRATEGY IN CERVICAL SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS (CSCCE), European journal of cancer, 31A, 1995, pp. 398-398
SECOND MALIGNANCIES (SM) IN ESOPHAGEAL CANCER (EC) AFTER COMBINED-MODALITY TREATMENT - IMPLICATIONS FOR FOLLOW-UP AND CHEMOPREVENTION
Authors: PARRA HS SANTORO A BIDOLI P SALVINI PM ANTONELLI G BONADONNA G
Citation: Hs. Parra et al., SECOND MALIGNANCIES (SM) IN ESOPHAGEAL CANCER (EC) AFTER COMBINED-MODALITY TREATMENT - IMPLICATIONS FOR FOLLOW-UP AND CHEMOPREVENTION, European journal of cancer, 31A, 1995, pp. 545-545
CLINICAL-SIGNIFICANCE OF SOLUBLE IL-2 RECEPTORS (S-IL-2R) IN HODGKINS-DISEASE (HD)
Authors: VIVIANI S DEVIZZI L BONFANTE V CAMERINI E SANTORO A FORNIER M VALAGUSSA P BONADONNA G
Citation: S. Viviani et al., CLINICAL-SIGNIFICANCE OF SOLUBLE IL-2 RECEPTORS (S-IL-2R) IN HODGKINS-DISEASE (HD), European journal of cancer, 31A, 1995, pp. 782-782
PACLITAXEL BY 3-HOUR INFUSION IN COMBINATION WITH BOLUS DOXORUBICIN IN WOMEN WITH UNTREATED METASTATIC BREAST-CANCER - HIGH ANTITUMOR EFFICACY AND CARDIAC EFFECTS IN A DOSE-FINDING AND SEQUENCE-FINDING STUDY
Authors: GIANNI L MUNZONE E CAPRI G FULFARO F TARENZI E VILLANI F SPREAFICO C LAFFRANCHI A CARACENI A MARTINI C STEFANELLI M VALAGUSSA P BONADONNA G
Citation: L. Gianni et al., PACLITAXEL BY 3-HOUR INFUSION IN COMBINATION WITH BOLUS DOXORUBICIN IN WOMEN WITH UNTREATED METASTATIC BREAST-CANCER - HIGH ANTITUMOR EFFICACY AND CARDIAC EFFECTS IN A DOSE-FINDING AND SEQUENCE-FINDING STUDY, Journal of clinical oncology, 13(11), 1995, pp. 2688-2699
Risultati: 1-25 | 26-50 | 51-75 | 76-87